Original articleMultiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
References (22)
- et al.
Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
Neuropsychopharmacology
(1996) - et al.
ICI 204,636, a novel atypical antipsychotic: Early indication of safety and efficacy in patients with chronic and subchronic schizophrenia
Clin Ther
(1995) Modified Scale for the Assessment of Negative Symptoms
- et al.
ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia
J Clin Psychopharmacol
(1996) - et al.
The activity of ‘Seroquel’ (ICI 204,636) in animal models for atypical properties of antipsychotics: A comparison with clozapine
Neuropsychopharmacology
(1996) The Analysis of Contingency Tables
(1992)Pre-clinical pharmacology of new atypical antipsychotics in late stage development
Expert Opin Invest Drugs
(1995)- et al.
ICI 204,636 (SEROQUEL™): A dibenzothiazepine atypical antipsychotic
Risperidone in the treatment of schizophrenia
Am J Psychiatry
(1994)
Cited by (0)
This trial was supported by a grant from Zeneca Pharmaceuticals.
- 1
See Appendix for individual members of the Seroquel Trial 13 Study Group.
Copyright © 1997 Published by Elsevier Inc.